Thomas Sciascia Trevi Therapeutics, Inc. (TRVI) insider trading activity
Thomas Sciascia is Chief Scientific Officer of Trevi Therapeutics, Inc.. Currently has a direct ownership of 220,315 shares of TRVI, which is worth approximately $934,135. The most recent transaction as insider was on Aug 19, 2024, when has been sold 16,496 shares (Common Stock) at a price of $2.96 per share, resulting in proceeds of $48,828. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
220K
0%
3M change
n/a
12M change
Total Value Held
$934,135
THOMAS SCIASCIA Transaction History
TS
Thomas Sciascia
Chief Scientific Officer
New Haven, CT